x ray diffraction and its application in pharma industry

PriyanshushekharAtre 85 views 25 slides Aug 05, 2024
Slide 1
Slide 1 of 25
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25

About This Presentation

x ray crystallography and its application in the formulation and development in pharma industries.


Slide Content

X-Ray Diffraction PRIYANSHU SHEKHAR ATRE M.S. Medicinal Chemistry (Jr. Officer, PLS)

1 2 3 4 5 6 7 1 INTRODUCTION 2 PRINCIPLE 3 DERIVATION OF BRAGG’S LAW 4 INSTRUMENTATION 5 QUALITATIVE ANALYSIS 6 QUANTITATIVE ANALYSIS 7 APPLICATION

X-ray diffraction (XRD) is a powerful analytical technique used for determining the atomic arrangement and molecular structure of a crystal.   X - RAY DIFFRACTOMETER P OWDER CRYSTALLINE AMORPHOUS

Why x-ray ? X-rays are a form of electromagnetic radiation with high energy and short wavelengths. X-rays have the ability to penetrate materials and interact with the electrons in atoms. Wilhelm Conrad Roentgen

Diffraction: - Diffraction is the bending of waves as they pass through an aperture or around obstacles. - X-ray diffraction occurs when X-rays encounter a crystalline material, leading to constructive and destructive interference.

Principle XRD is based on the interaction between X-rays and electron clouds of atoms. THE BRAGG EQUATION is crucial here, describing how X-rays are diffracted by crystal lattice planes. When the X-ray is incident onto a crystal surface, its angle of incidence, θ , will reflect with the same angle of scattering, θ. And, when the path difference, d is equal to a whole number, n , of wavelength, λ , constructive interference will occur. CONSTRUCTIVE INTERFERENCE DESTRUCTIVE INTERFERENCE     λ d  

P R Q S Derivation of Braggs law Lets consider, PQ is first plain surface of crystal & RS is second surface. Surface 1 Surface 2

θ θ B A P R Q S Lets consider, PQ is first plain surface of crystal & RS is second surface. Two parallel beam (AX & BO) of X-rays incident on plain surface with angle ‘ θ ’. O X ∠AXR =   ∠ BOP d Incident beam Θ : angle between incident ray and lattice planes d : Distance between successive crystal lattice planes

θ θ θ θ O B A C D X P R Q S Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. ∠AXR =   ∠ DXS ∠BOP =   ∠ COQ d ∠AXR =   ∠ BOP Incident beam diffracted beam

θ θ θ O B A C D X P R Q S E F Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. AE = BO , But second beam travels extra Extra travel = EX + XF As per constructive interference, extra path travelled is integral multiple of the waveleanth . So, Extra travel = n λ EX + XF = n λ 2EX = n λ as (EX = XF) ∠BOE = 90° d Incident beam diffracted beam

θ θ θ (90- θ ) O B A C D X P R Q S E F EX + XF = n λ 2EX = n λ ∠BOE = 90° i.e. ∠POE = (90°- θ ) d eq.01 Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. Incident beam diffracted beam

θ θ θ O B A C D X P R Q S E F ∠BOE = 90° i.e. ∠POE = (90°- θ ) ∠POX = 90° d Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. EX + XF = n λ 2EX = n λ eq.01

θ θ θ θ θ O B A C D X P R Q S E F i.e. ∠EOX =  θ ∠POX = 90° d Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. EX + XF = n λ 2EX = n λ eq.01 Incident beam diffracted beam

θ θ θ θ θ O B A C D X P R Q S E F IN △ EOX, d   , (OX = d) Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. EX + XF = n λ 2EX = n λ eq.01 EX = d sin θ eq.02 ∠EOX =  θ Incident beam diffracted beam

θ θ θ θ θ O B A C D X P R Q S E F d Lets consider, PQ is first plain surface of crystal & RS is second surface. Now, parallel beam scatter from the point of incidence with angle ‘ θ ’. 2EX = n λ eq.01 EX = d sin θ eq.02 ∠EOX =  θ Substitute eq.02 in eq.01 2d sin θ = n λ BRAGG’S LAW EXPRESSION Incident beam diffracted beam

Instrumentation and Working of XRD Instrument: - XRD instruments include X-ray sources, monochromators, sample stages, and detectors. - They operate by measuring the intensity of diffracted X-rays at various angles. G oniometer - It measures an angle or permits the rotation of an object to a definite position. Specimen Holder THE BRAGG-BRENTANO GEOMETRY

INSTRUMENTATION AND WORKING OF XRD INSTRUMENT: DETECTORS: Photographic method Laue method Counter methods Geiger-Muller tube counter Proportional counter Scintillation detector Semi conductor detector Laue Method Scintillation Detector Geiger-Muller tube counter

XRD graph interpretition Sharp peak Broad peak

Peak Intensity Peak Position Qualitative Phase Analysis (Identification of Phases) This involves comparing the X-ray pattern of an unknown sample with patterns of known reference materials. Computer-aided comparisons use data like 2θ diffraction angles and d-spacings. Organic crystals are typically analyzed in a 2θ range up to 30°. Reference peak Sample peak

ERRORS in Qualitative phase analysis Sample displacement - Misalignment of sample.

TiO 2 defract X ray more efficiently so it has more intense peak Intensity of peak cannot define the amount of phase present. Its need proper calibration Phase analysis of Mixture of titanium oxide and Aluminium oxide by comparision with database

Quantitative Phase Analysis If a sample contains multiple phases, quantitative analysis determines the percentage of each phase. This can be done by comparing integrated intensities or peak heights with reference materials. External standard – Diffraction intensity of a phase in a mixture compare against the diffraction intensity of a pure phase. Internal standard- Diffraction intensity of a phase in sample is compare against the pure phase which is spiked in sample in known proportion. Rietveild refinement- instead of focusing particular peaks , whole diffraction pattern must take under consideration for the interpretation.

Applications in Pharmaceuticals : - XRD is used to identify polymorphism in drug compounds. - Different polymorphs have distinct XRD patterns, helping in drug development and quality control. Polymorphism is the ability of solid materials to exist in two or more crystalline forms with different arrangements or conformations of the constituents in the crystal lattice.  P olymorphic forms affects Dissolution Solubility Chemical nature Physical stability Flowability Hygroscopicity D rug efficacy hampered B ioavailability compromised Toxicity may occur

XRD can detect different polymorphs based on their unique diffraction patterns. Small changes in the X-ray powder patterns can imply the presence of a new polymorph such as, The appearance of new peak(s), Additional shoulders or Shifts in the peak position

Thank you